Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation-Reference-Cited by-同舟云学术

Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation

Published:2009-07 Issue:7 Volume:64 Page:995-1002
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:

Author:

Perros F.,Hoogsteden H. C.,Coyle A. J.,Lambrecht B. N.,Hammad H.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1398-9995.2009.02095.x/fullpdf

Reference30 articles.

1. To respond or not to respond: T cells in allergic asthma;Herrick;Nat Rev Immunol,2003

2. Taking our breath away: dendritic cells in the pathogenesis of asthma;Lambrecht;Nat Rev Immunol,2003

3. In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma;van Rijt;J Exp Med,2005

4. Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells;Rivino;J Exp Med,2004

5. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes;Sallusto;J Exp Med,1998

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single‐cell profiling highlight pathogenic myeloid features in house dust mite‐induced murine model of airway inflammation;Allergy;2024-05-13

2. ERK/STAT3 activation through CCL17/CCR4 axis-mediated type 2 cytokine-involved signaling pathways in Th2 cells regulates cutaneous drug reactions;International Immunopharmacology;2024-03

3. Identification of key genes and biological pathways in chronic obstructive pulmonary disease using bioinformatics and next generation sequencing data analysis;2024-02-14

4. Randomized double‐blind placebo‐controlled cosmetic trial of a topical first‐in‐class Neutraligand targeting the chemokine TARC/CCL17 in mild‐to‐moderate atopic dermatitis;International Journal of Cosmetic Science;2024-02-07

5. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs;Nature Reviews Drug Discovery;2023-08-01